Introduction:
In today’s rapidly evolving pharmaceutical industry, efficiency and accuracy are paramount to success. Companies are constantly seeking innovative ways to streamline their processes while maintaining strict compliance with regulatory requirements. One such company that has made significant strides in this area is VEQTOR, a leader in digital validation solutions.
In this blog post, we will explore VEQTOR’s groundbreaking out-of-the-box solution and its successful implementation for Dechra Pharmaceutical PLC, thanks to the valuable insights shared by Phil Jarvis, Director of integrated C&Q and kneat services and a key player at VEQTOR Solutions.
This validation process unveils the fascinating journey of VEQTOR’s collaboration with Dechra Pharmaceutical. Before diving into the specifics, let’s take a brief look at the background of VEQTOR and the pharmaceutical giant Dechra.
VEQTOR’s Background:
VEQTOR is a leading provider of digital validation solutions, committed to revolutionizing the pharmaceutical industry through cutting-edge technology. With a team of experts and a global presence, VEQTOR has successfully developed an out-of-the-box solution that has the potential to transform validation processes for pharmaceutical companies worldwide.
Dechra Pharmaceutical PLC:
Dechra Pharmaceutical PLC is a prominent player in the veterinary pharmaceutical space. The company has a global presence and is continuously expanding its reach. Facing the challenges of an expanding global presence, Dechra sought a more centralized and efficient digital validation solution for their computer system validation (CSV) projects.
The Deployment to Dechra:
The recent publication highlighting the successful deployment of VEQTOR’s out-of-the-box solution for Dechra Pharmaceutical PLC.
“Reducing Digital Validation Implementation Time by 60% for Dechra Pharmaceuticals PLC”
They discuss the significance of Dechra’s choice to opt for an out-of-the-box methodology rather than a custom rollout for their CSV projects.
Why Choose the Out-of-the-Box Solution?
Dechra’s decision to select the out-of-the-box solution was primarily driven by the need to deliver results quickly and efficiently for a specific project, the electronic submission module. The company had a strict timeline and wanted to prove the ROI of using a digital validation system.
VEQTOR’s out-of-the-box solution, which was already fit for purpose and certified by Kneat, provided the perfect solution to meet Dechra’s timeline requirements.
Time-Saving Benefits of the Out-of-the-Box Solution
One of the main advantages of VEQTOR’s out-of-the-box solution is the significant time saved during implementation. Unlike custom rollouts, which involve detailed process mapping and configuration, the out-of-the-box solution already provides a pre-configured, risk-based approach that aligns with industry best practices.
Dechra was able to quickly adapt the solution to its specific needs, cutting down the implementation timeline from 12-15 weeks to just 6 weeks.
Benefits Beyond Time-Saving:
Aside from time savings, Dechra enjoyed various other benefits from the out-of-the-box solution. The turnkey solution included all the necessary Standard Operating Procedures (SOPs) required for system use, along with CSV documents for validation of the system . This allowed Dechra to validate the solution for their intended use efficiently. VEQTOR also provided hypercare support during the initial implementation, ensuring a smooth transition and immediate benefits.
The Future of Out-of-the-Box Solutions:
Looking ahead, VEQTOR envisions a bright future for its out-of-the-box solutions. They constantly evolving and expanding its offerings to provide a diverse menu of solutions for clients. With a strong focus on scalability and global presence, VEQTOR aims to cater to various disciplines and industries, facilitating digitization and enhancing efficiencies worldwide.
Conclusion:
VEQTOR’s out-of-the-box solution has proven to be a game-changer for Dechra Pharmaceutical PLC, revolutionizing their validation processes and driving substantial time savings. With a strong partnership between VEQTOR and Kneat, the future looks promising for the pharmaceutical industry, as more companies embrace digital transformation and optimize their validation processes. As technology continues to advance and innovative solutions emerge, the possibilities for enhanced efficiency and compliance in the pharmaceutical sector are truly limitless.
We want to thank Phil Jarvis the Director of integrated C&Q and Kneat services at VEQTOR Solutions for his contribution & his expert insights in this blog post.
With extensive experience as the Director of integrated C&Q and kneat services at VEQTOR Solutions, Phil has played a pivotal role in revolutionizing validation processes for the pharmaceutical industry. His insights into the transformative out-of-the-box solution deployed at Dechra Pharmaceutical PLC provide a unique perspective on the intersection of technology and efficiency in this sector.
